Human Genome Center, Institute of Medical Science, University of Tokyo
38
0
0
19
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
13.2%
5 terminated/withdrawn out of 38 trials
79.2%
-7.3% vs industry average
0%
0 trials in Phase 3/4
5%
1 of 19 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (38)
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Small Cell Lung Cancer
Role: collaborator
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer
Role: collaborator
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung Cancer
Role: collaborator
Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer
Role: collaborator
Peptide Vaccine and S-1/CPT-11 Therapy for Patients With Unresectable Advanced Colorectal Cancer
Role: collaborator
Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer
Role: collaborator
Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer
Role: collaborator
Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)
Role: collaborator
Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer
Role: collaborator
Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy
Role: collaborator
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer
Role: collaborator
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer
Role: collaborator
Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer
Role: collaborator
Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer
Role: collaborator
Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors
Role: collaborator
Novel Peptide Vaccination for Patients With Advanced Prostate Cancer
Role: collaborator
Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer
Role: collaborator
Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)
Role: collaborator
Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma
Role: collaborator
HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)
Role: collaborator